Global Cell and Gene Therapy Manufacturing Services Market to reach USD 15630.64 million by 2027

Global Cell and Gene Therapy Manufacturing Services Market is segmented by Type (Cell, Gene), Indication (Oncology, Cardiology, Orthopedic, Other), Mode (In-house, Contract), End-user Industry (Pharm & Biotechnology, Academic and Research Institute ),Regional Forecasts 2021-2027
Product Code:  HALB_10677038
Chapter 1. Executive Summary 
 1.1. Market Snapshot
 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
 1.2.1. Cell and Gene therapy Manufacturing Services Market, by Region, 2019-2027 (USD Million)
 1.2.2. Cell and Gene therapy Manufacturing Services Market, by Type, 2019-2027 (USD Million)
 1.2.3. Cell and Gene therapy Manufacturing Services Market, by Indication, 2019-2027 (USD Million)
 1.2.4. Cell and Gene therapy Manufacturing Services Market, by Mode, 2019-2027 (USD Million)
 1.2.5. Cell and Gene therapy Manufacturing Services Market, by End user, 2019-2027 (USD Million)
 1.3. Key Trends
 1.4. Estimation Methodology
 1.5. Research Assumption
 Chapter 2. Global Cell and Gene therapy Manufacturing Services Market Definition and Scope 
 2.1. Objective of the Study
 2.2. Market Definition & Scope
 2.2.1. Scope of the Study
 2.2.2. Industry Evolution
 2.3. Years Considered for the Study
 2.4. Currency Conversion Rates
 Chapter 3. Global Cell and Gene therapy Manufacturing Services Market Dynamics 
 3.1. Cell and Gene therapy Manufacturing Services Market Impact Analysis (2019-2027)
 3.1.1. Market Drivers
 3.1.1.1. Increasing investments of pharmaceutical companies in the Research & Development
 3.1.1.2. Increase in the number of chronic diseases, orthopaedics and other cardiovascular diseases
 3.1.2. Market Restraint
 3.1.2.1. increasing in the operational costs
 3.1.3. Market Opportunities
 3.1.3.1. increase in the number of clinical therapies for cell and gene therapies
 Chapter 4. Global Cell and Gene therapy Manufacturing Services Market Industry Analysis
 4.1. Porter’s 5 Force Model
 4.1.1. Bargaining Power of Suppliers
 4.1.2. Bargaining Power of Buyers
 4.1.3. Threat of New Entrants
 4.1.4. Threat of Substitutes
 4.1.5. Competitive Rivalry
 4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
 4.2. PEST Analysis
 4.2.1. Political 
 4.2.2. Economical
 4.2.3. Social 
 4.2.4. Technological 
 4.3. Investment Adoption Model
 4.4. Analyst Recommendation & Conclusion
 Chapter 5. Global Cell and Gene therapy Manufacturing Services Market, by Type
 5.1. Market Snapshot 
 5.2. Global Cell and Gene therapy Manufacturing Services Market by Type , Performance - Potential Analysis
 5.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Million)
 5.4. Cell and Gene therapy Manufacturing Services Market , Sub Segment Analysis
 5.4.1. Cell
 5.4.2. Gene
 Chapter 6. Global Cell and Gene therapy Manufacturing Services Market, by Indication
 6.1. Market Snapshot 
 6.2. Global Cell and Gene therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
 6.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Million)
 6.4. Cell and Gene therapy Manufacturing Services Market , Sub Segment Analysis
 6.4.1. Oncology
 6.4.2. Cardiology
 6.4.3. Orthopaedic
 6.4.4. Others
 Chapter 7. Global Cell and Gene therapy Manufacturing Services Market, by Mode
 7.1. Market Snapshot 
 7.2. Global Cell and Gene therapy Manufacturing Services Market by Mode, Performance - Potential Analysis
 7.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Mode 2018-2027 (USD Million)
 7.4. Cell and Gene therapy Manufacturing Services Market , Sub Segment Analysis
 7.4.1. In house manufacturing
 7.4.2. Contract manufacturing 
 Chapter 8. Global Cell and Gene therapy Manufacturing Services Market, by End user industry
 8.1. Market Snapshot 
 8.2. Global Cell and Gene therapy Manufacturing Services Market by End user industry, Performance - Potential Analysis
 8.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by End user industry 2018-2027 (USD Million)
 8.4. Cell and Gene therapy Manufacturing Services Market , Sub Segment Analysis
 8.4.1. Pharmaceutical and Biotechnology companies
 8.4.2. Academic and research institute
 Chapter 9. Global Cell and Gene therapy Manufacturing Services Market, Regional Analysis
 9.1. Cell and Gene therapy Manufacturing Services Market , Regional Market Snapshot 
 9.2. North America Cell and Gene therapy Manufacturing Services Market 
 9.2.1. U.S. Cell and Gene therapy Manufacturing Services Market
 9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
 9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
 9.2.1.3. Mode breakdown estimates & forecasts, 2018-2027
 9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
 9.2.2. Canada Cell and Gene therapy Manufacturing Services Market
 9.3. Europe Cell and Gene therapy Manufacturing Services Market Snapshot
 9.3.1. U.K. Cell and Gene therapy Manufacturing Services Market 
 9.3.2. Germany Cell and Gene therapy Manufacturing Services Market
 9.3.3. France Cell and Gene therapy Manufacturing Services Market
 9.3.4. Spain Cell and Gene therapy Manufacturing Services Market
 9.3.5. Italy Cell and Gene therapy Manufacturing Services Market
 9.3.6. Rest of Europe Cell and Gene therapy Manufacturing Services Market
 9.4. Asia-Pacific Cell and Gene therapy Manufacturing Services Market Snapshot
 9.4.1. China Cell and Gene therapy Manufacturing Services Market 
 9.4.2. India Cell and Gene therapy Manufacturing Services Market 
 9.4.3. Japan Cell and Gene therapy Manufacturing Services Market
 9.4.4. Australia Cell and Gene therapy Manufacturing Services Market
 9.4.5. South Korea Cell and Gene therapy Manufacturing Services Market
 9.4.6. Rest of Asia Pacific Cell and Gene therapy Manufacturing Services Market
 9.5. Latin America Cell and Gene therapy Manufacturing Services Market Snapshot
 9.5.1. Brazil Cell and Gene therapy Manufacturing Services Market
 9.5.2. Mexico Cell and Gene therapy Manufacturing Services Market
 9.6. Rest of The World Cell and Gene therapy Manufacturing Services Market
 Chapter 10. Competitive Intelligence
 10.1. Top Market Strategies
 10.2. Company Profiles
 10.2.1. Thermo fisher Scientific Inc.
 10.2.1.1. Key Information
 10.2.1.2. Overview
 10.2.1.3. Financial (Subject to Data Availability)
 10.2.1.4. Product Summary
 10.2.1.5. Recent Developments
 10.2.2. Merck KGaA
 10.2.3. Charles River Laboratories
 10.2.4. Lonza
 10.2.5. Catalent, Inc.
 10.2.6. Takara Bio Inc.
 10.2.7. Fujifilm Holdings Corporation
 10.2.8. Roche Ltd
 10.2.9. Wuxi Advanced Therapies
 10.2.10. Cell and Gene Therapy Catapult
 Chapter 11. Research Process
 11.1. Research Process
 11.1.1. Data Mining
 11.1.2. Analysis
 11.1.3. Market Estimation
 11.1.4. Validation
 11.1.5. Publishing
 11.2. Research Attributes
 11.3. Research Assumption

Global Cell and Gene Therapy Manufacturing Services Market is valued approximately at USD 7367.01 million in 2020 and is anticipated to grow with a healthy growth rate of more than 12.34% over the forecast period 2021-2027. The area of cell and gene therapy is revolutionizing way cancer patients and those with genetic disorders are treated. These new therapeutic possibilities enhance patient outcomes dramatically and, in some situations, are curative. However, manufacturing of such medicines poses complex new challenges. The cost of manufacture remains a significant barrier to clinical translation and commercialization of these potentially game-changing medicines today. To manufacture high-quality medications in a reliable and cost-effective manner, new technologies are required. While patients will benefit from new treatment options, the risks for patients and drug developers are high. The market is driven by the key factors such as Increasing investments of pharmaceutical companies in the Research & Development and Increase in the number of chronic diseases, orthopaedic and other cardiovascular diseases. major pharma firms are boosting their R&D efficiency by investing heavily in R&D, in order to ensure long returns on investments, as well as by collaborating with the R&D centres worldwide. for instance: According to Statista, Roche is expected to be the world’s largest company which is investing heavily in R&D, that is, USD 14 Billion followed by Johnson & Johnson (USD 12.2 Billion), Merck & Co (USD 11.4 Billion), Pfizer (USD 10.5 Billion) and Novartis (USD 10 Billion), by the year 2026. However, increasing in the operational costs, may impede market growth over the forecast period of 2021-2027.

Geographically, North America is Dominating the market shares of Cell and gene therapy manufacturing services market owing to rising strategic steps taken by private players and growing number of cancer cases in the region. Furthermore, United States market consists of many prominent players in cell and gene therapy manufacturing services, which are taking strategic steps such as technological advancements, mergers and others to develop new solutions for gene and cell therapy. However, APAC is estimated to be the fastest growing region due to growing development in research and development in cell and gene therapy. Also, China is expected to grow with the highest growth rate during forecast period, due to rising number of approvals by government authorities and growing industrialization of cell and gene therapy in the region

Major market player included in this report are:
Thermo fisher Scientific Inc.
Merck KGaA
Charles River Laboratories
Lonza
Catalent, Inc.
Takara Bio Inc.
Fujifilm Holdings Corporation
Roche Ltd
Wuxi Advanced Therapies
Cell and Gene Therapy Catapult

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Types of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Cell
Gene
By Indication:
Oncology
Cardiology
Orthopedic
Other
By Mode:
In house
Contract
By End user:
Pharma and Biotechnology companies
Academic and research Institute
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Cell and Gene Therapy Manufacturing Services Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…